Cargando…

Speculation of the Time-Dependent Change of FIB4 Index in Patients with Nonalcoholic Fatty Liver Disease: A Retrospective Study

AIM: To speculate on the time-dependent change of FIB4 index in patients with nonalcoholic fatty liver disease (NAFLD) and its increase-decrease rate per year, simply and accurately. METHODS: In all 23 patients with NAFLD with the value of FIB4 index over 1.30 at the peak, the period from the first...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyata, Hiroshi, Miyata, Satoru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867539/ https://www.ncbi.nlm.nih.gov/pubmed/29721486 http://dx.doi.org/10.1155/2018/5323061

Ejemplares similares

Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population
por: Sumida, Yoshio, et al.
Publicado: (2012)

The Appropriate Opportunity for Evaluating Liver Fibrosis by Using the FIB-4 Index in Patients with Nonalcoholic Fatty Liver Disease in Japan
por: Seko, Yuya, et al.
Publicado: (2020)

FRI429 Association Between Nonalcoholic Fatty Liver Disease And Fib-4 In Patients With Hypogonadism
por: Godar, Cassandra M, et al.
Publicado: (2023)

The FIB-4 Index Is a Useful Predictor for the Development of Hepatocellular Carcinoma in Patients with Coexisting Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B
por: Kim, Minah, et al.
Publicado: (2021)

Analysis of time-dependent changes in the FIB4 index in patients with obesity receiving weight reduction therapy
por: Kawai, Shiori, et al.
Publicado: (2022)

Fibroscan Compared to FIB-4, APRI, and AST/ALT Ratio for Assessment of Liver Fibrosis in Saudi Patients With Nonalcoholic Fatty Liver Disease
por: Fallatah, Hind I., et al.
Publicado: (2016)

Liver Fibrosis Index FIB‐4 Is Associated With Mortality in COVID‐19
por: Li, Yijia, et al.
Publicado: (2020)

Assessing Liver Fibrosis Using the FIB4 Index in the Community Setting
por: Blanco-Grau, Albert, et al.
Publicado: (2021)

Diagnostic Accuracy of FIB-4 and FIB-5 Scores as Compared to Fibroscan for Assessment of Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease
por: Kumari, Bandana, et al.
Publicado: (2021)

Novel multi-parametric diagnosis of non-alcoholic fatty liver disease using ultrasonography, body mass index, and Fib-4 index
por: Funada, Kei, et al.
Publicado: (2023)

Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease
por: Park, Huiyul, et al.
Publicado: (2023)

Clinical impact of atrophic changes in remnant pancreas on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy
por: Yamamura, Kensuke, et al.
Publicado: (2022)

FIB-4 Index and Diabetes Mellitus Are Associated with Chronic Kidney Disease in Japanese Patients with Non-Alcoholic Fatty Liver Disease
por: Seko, Yuya, et al.
Publicado: (2019)

What Motivates Speculators to Speculate?
por: Gemeda, Bedane S., et al.
Publicado: (2019)

FIB-5 versus FIB-4 index for assessment of hepatic fibrosis in chronic hepatitis B affected patients
por: Metwally, Khaled, et al.
Publicado: (2020)

Fatty Liver Index for Predicting Nonalcoholic Fatty Liver Disease in an Asymptomatic Korean Population
por: Cho, Eun-Ju, et al.
Publicado: (2021)

Aspartate transaminase to platelet ratio index (APRI) but not FIB-5 or FIB-4 is accurate in ruling out significant fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) in an urban slum-dwelling population
por: Kolhe, Kailash Marotrao, et al.
Publicado: (2019)

Accuracy of Ultrasound Elastography and Fibrosis-4 Index (FIB-4) in Ruling Out Cirrhosis in Obese Non-Alcoholic Fatty Liver Disease (NAFLD) Patients
por: Damjanovska, Sofi, et al.
Publicado: (2022)

The association of dietary phytochemical index and nonalcoholic fatty liver disease
por: Ahmadi, Bijan, et al.
Publicado: (2023)

Validation of the Fatty Liver Index for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Chinese
por: Huang, Xiaolin, et al.
Publicado: (2015)

Itch in Liver Disease: Facts and Speculations
por: Ghent, Cameron N., et al.
Publicado: (1979)

FIB-4 index is a marker for a subsequent decrease in insulin secretion in a non-diabetic Japanese population
por: Fujita, Tomoyuki, et al.
Publicado: (2020)

The liver fibrosis index is superior to the APRI and FIB-4 for predicting liver fibrosis in chronic hepatitis B patients in China
por: Huang, Dedong, et al.
Publicado: (2019)

Impact of Nutritional Changes on Nonalcoholic Fatty Liver Disease
por: Perdomo, Carolina M., et al.
Publicado: (2019)

Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease
por: Srivastava, Ankur, et al.
Publicado: (2019)

FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic
por: Sumida, Yoshio, et al.
Publicado: (2021)

Risk factor compositions of nonalcoholic fatty liver disease change with body mass index in males and females
por: Wang, Long, et al.
Publicado: (2016)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Combining serum uric acid and fatty liver index to improve prediction quality of nonalcoholic fatty liver disease
por: Ding, Yajie, et al.
Publicado: (2023)

Linguistic speculations
por: Householder, Fred W. (Fred Walter), 1913-
Publicado: (1971)

Medical Speculations
Publicado: (1804)

Nonalcoholic Fatty Liver Disease: Time to Take the Bull by the Horns
por: Nath, Preetam, et al.
Publicado: (2018)

Inferior vena cava collapsibility index: Speculation, mirage, or reality?
por: Bajwa, Sukhminder Jit Singh, et al.
Publicado: (2022)

Hepatorenal Index by B‐Mode Ratio Versus Imaging and Fatty Liver Index to Diagnose Steatosis in Alcohol‐Related and Nonalcoholic Fatty Liver Disease
por: Kjaergaard, Maria, et al.
Publicado: (2022)

Elevated liver fibrosis index FIB-4 is not reliable for HCC risk stratification in predominantly non-Asian CHB patients
por: Demir, Münevver, et al.
Publicado: (2016)

The FIB-4 Index Predicts the Development of Liver-Related Events, Extrahepatic Cancers, and Coronary Vascular Disease in Patients with NAFLD
por: Kamada, Yoshihiro, et al.
Publicado: (2022)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Retinol-binding protein-4 and nonalcoholic fatty liver disease
por: Huang, Hangkai, et al.
Publicado: (2022)

Involvement of Periodontal Disease in the Pathogenesis and Exacerbation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: A Review
por: Kobayashi, Takashi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o0usevkud8ipec9cu35jqps4ml